NTRA: Natera Company Short-Term Debt

Graphic logo of Natera, Inc. (NTRA)

Natera, Inc. optimizes reagent and equipment procurement to minimize supply risks. Total short-term liabilities help assess financial autonomy, with the most recent value recorded as 0.11. Stable demand for non-invasive diagnostics ensures a steady order flow, while strategic alliances in oncogenetics and the acquisition of molecular technologies create powerful synergies for business growth.

NTRA (Natera Inc) Company Short-Term Indebtedness history from 07/04/2022 to 10/31/2026

NTRA (Natera Medical): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Natera|NTRA - Fair Value Consensus
- market capitalization information:
Market Value Natera, Inc.|NTRA - Total Enterprise Value
- shareholders' equity book value data:
Book Value per Share Natera|NTRA - Accounting Capitalization|Market Cap to Net Assets Ratio natera.com|NTRA - Company Total Assets
- debt and liquidity details:
Total Debt to Capital Natera, Inc.|NTRA - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Natera, Inc.|NTRA - Company Cumulative Indebtedness|Debts to Book Capitalization Natera, Inc.|NTRA - Long-Term Debt Volume|Company Short-Term Debt Natera|Quick Liquidity natera.com
- net income and valuation multiples indicators:
NTRA - Company Profit
Summary company analytics:Natera (NTRA)
Manufactured products of natera.com

Natera, Inc. (NTRA) investments in recruiting leading bioinformaticians require strict control over short-term financial liabilities. This indicator aggregates all obligations due for settlement within the next operating cycle. The metric is calculated as the sum of current loans and accrued interest. A reduction in this volume confirms high capital liquidity, while a stable downward trend guarantees the company's resilience to market shocks.

Competitors of Natera, Inc.

HUMA - Company Short-Term Debt|Company Short-Term Loans and Borrowings SERA (Sera Prognostics Inc.)